NCT04031352

Investigation of Factors Affecting Children's Attitudes Towards Peers With Disability

Name: Clinical Trial NCT04031352
Creator: Pamukkale University
Keywords: Disability Physical, implementation of CATCH scale, other, clinical trial, Turkey

Pamukkale University·ClinicalTrials.gov·otherCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Disability Physical
Drug/Device/Intervention: implementation of CATCH scale
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Pamukkale University
Location: Denizli, Turkey

Timeline & enrollment

Phase: N/A
Start date: Mar 14, 2017
End date: Jun 16, 2018
Enrollment: 1305 participants

Primary outcome

CATCH

Summary

Children with disabilities can be exposed to stigma and discrimination because of poor attitudes. The role of peer is crucial for development of disabled children.  The aim of the study was to investigate the attitudes of children towards their peers with disabilities and to identify factors associated with them.  1305 elementary school students included to the study. The students participating in the study, 48.9% (534) were female, 51.1% (558) were male. The Chedoke-McMaster Attitudes towards Children with Handicaps (CATCH) scale was used to investigate the children's attitudes.

ICD-10 classifications

Other physical therapyLimitation of activities due to disabilityDependence on wheelchairPostprocedural musculoskeletal disorders, not elsewhere classifiedFamily history of other disabilities and chronic diseases leading to disablement, not elsewhere classified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04031352
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04031352 through Pure Global AI's free database. This phase not specified trial is sponsored by Pamukkale University and is currently Completed. The study focuses on Disability Physical. Target enrollment is 1305 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.